Article
Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Pathology, research and practice - 1 Dec 2020
Liu Ji, Li Xu, Yang Shanshan, Mou Junjun, Lu Haijun
Abstract excerpt
BACKGROUND: To date, no targeted therapy has been approved for nasopharyngeal carcinoma (NPC), suggesting that comprehensive understanding of genomic changes turns out to be an urgent need to break through the calm of currently known therapies of NPC. METHODS: Whole exome sequencing (WES) was performed for 14 NPC patients, including 6 NPC-IIA cases, 8 NPC-IIB cases. The cancer chip expression data named GSE12452...
Topics
Join the communities discussing this publication.
